A resolution expressing support for the designation of July 2024 as "National Sarcoma Awareness Month".
Latest Action
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4564)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™Senate Resolution 764 from the 118th Congress is a non-binding resolution expressing support for designating July 2024 as "National Sarcoma Awareness Month." The resolution aims to raise public awareness about sarcoma, a type of cancer, by encouraging recognition and education during the month of July 2024. The resolution was referred to the Senate Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further legislative action. The bill text and official summary are not provided, limiting detailed analysis.
This resolution sought to promote awareness of sarcoma by designating July 2024 as a dedicated awareness month but did not advance beyond committee referral and expired without enactment.
- The resolution supports the designation of July 2024 as National Sarcoma Awareness Month.
- It was introduced in the Senate during the 118th Congress and referred to the Committee on Health, Education, Labor, and Pensions.
- The resolution did not pass and is listed as failed or expired as of April 2025.
['Individuals affected by sarcoma, including patients and their families', 'Health advocacy organizations focused on cancer awareness', 'Medical and research communities involved in sarcoma treatment and study']
['As a non-binding resolution, it does not allocate funding or create enforceable obligations, limiting direct impact.', 'Lack of detailed bill text and summary restricts understanding of specific measures or awareness activities proposed.', 'No oversight or implementation mechanisms are specified, which may affect the effectiveness of awareness efforts.']
The resolution was introduced in the Senate and referred to the Committee on Health, Education, Labor, and Pensions during the 118th Congress. It aligns with common congressional practice of designating awareness months to highlight health issues. The resolution did not advance beyond committee referral and expired, indicating limited legislative momentum or prioritization.
No hidden impact flags detected
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public awareness about sarcoma could lead to greater support for research and patient resources.', 'Recognition of sarcoma awareness month may encourage healthcare providers to focus on early detection and education.', 'Potential for advocacy groups to leverage the designation for fundraising and outreach activities.']
The resolution lacks detailed legislative text and an official summary, limiting transparency about specific awareness activities or goals. Its non-binding nature means it does not create enforceable obligations or funding, which should be noted when assessing its potential impact. The failure to advance beyond committee referral suggests limited legislative engagement or prioritization.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.